Finance minister Nirmala Sitharaman unveiled the Union Budget 2026-27, introducing Biopharma Shakti with a Rs 10,000 crore ...

Pharma stocks experienced a significant surge after Finance Minister Nirmala Sitharaman announced the Rs 10,000 crore ...

Finance Minister Nirmala Sitharaman announces Biopharma Shakti, a ₹10,000 crore plan to boost biologics, biosimilars, clinical trials and regulatory capacity in India.

The Union Budget 2026–27 proposed a Rs 10,000 crore Bio Pharma Shakti scheme to boost biologics and biosimilars, alongside ...

Finance Minister Nirmala Sitharaman, in her budget speech, unveiled “Biopharma Shakti”, a ₹10,000-crore strategy aimed at ...

Finance Minister Nirmala Sitharaman on Sunday proposed a Rs 10,000 crore allocation over the next five years to boost India’s ...

Union Budget 2026 unveiled a Rs 10,000 crore Biopharma Shakti mission to boost advanced medicine production, tackle rising diabetes and obesity, and strengthen India’s fight against non-communicable ...

Finance Minister Nirmala Sitharaman, during her ninth consecutive Budget speech, announced an outlay of ₹10,000 crore under ...

Finance Minister Sitharaman said that since the Modi Government assumed office, the economy has been marked by a state of ...

The BioPharma Shakti initiative aims to strengthen research, clinical trials, and regulatory capacity amid India’s rising non ...

The finance minister Nirmala Sitharaman introduced a new scheme "Biopharma Shakti" with an outlay of INR 10,000 Cr for the upcoming five years.

Union Budget 2026 highlights Biopharma Shakti with an outlay of Rs 10K crore, aimed at boosting India's biopharma, biotech, innovation, healthcare research, and life sciences ecosystem.